Hanne Capital appeared to be the VC, which was created in 2017.
Besides them, we counted 1 critical employee of this fund in our database.
The typical case for the fund is to invest in rounds with 4-5 participants. Despite the Hanne Capital, startups are often financed by Nest.Bio Ventures, Viventures, Sequoia Capital China. The meaningful sponsors for the fund in investment in the same round are VI Ventures, Sequoia Capital China, Legend Star.
Among the various public portfolio startups of the fund, we may underline HiFiBiO Among the most successful fund investment fields, there are Pharmaceutical, Health Care. Besides, a startup requires to be at the age of 6-10 years to receive the investment from the fund.
The usual things for fund are deals in the range of 50 - 100 millions dollars. The important activity for fund was in 2019. The fund is constantly included in 2-6 deals per year.
Funds with similar focus
|$9M||08 Jan 2021||Dongcheng District, Beijing, China|
|$25M||20 Oct 2020||China, Shanghai|
|$7M||01 Sep 2020||-|
|$20M||31 Aug 2020||Washington, United States|
|$5M||29 Jun 2020||Guangdong Province|
EOC Pharma Group
|$77M||02 Dec 2019||Shanghai|
|$10M||27 Sep 2019||Guangdong Province|
|$67M||28 Aug 2019||Paris, Ile-de-France, France|
|$14M||21 Jan 2019||Zhejiang|
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.